User: Guest

  



DOMAIN EXPERT ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

510

Interactions with Platform & by Email *

INTERACTIONS

102

Unique # Participated *

PARTICIPANTS

20

Responses Validated *

VALIDATIONS

8

* Platform engagements are dynamic. Stats are published quarterly.


  •  CODE

  •  PAGES

  •  DATE

  •  PRICE

    $

  •  DATA EXHIBITS

    125


TABLE OF CONTENTS


   Pages :    | $

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Global & Regional Market Analysis.....II-1
Opportunities in VAD Market.....II-1
Destination Therapy – An Immense Potential Opportunity.....II-1
1$100
   Next Generation Devices to Offer Pronounced Scope.....II-2
Heart Transplantation Scenario.....II-2
Table 1: Number of Heart Transplants Worldwide (2000-2006) (In Units) (includes corresponding Graph/Chart).....II-2
1$300
   Table 2: Heart Transplants Worldwide (2008E): Percentage Share Breakdown by Country/Region (includes corresponding Graph/Chart).....II-3
1$300
   Thoratec is the Clear Leader.....II-4
Leading Players in the Global VAD Market.....II-4
Table 3: Leading Players in the Global VAD and Circulatory Support Market (2007): Percentage Breakdown of Value Sales for Thoratec, Abiomed, WorldHeart and Others (includes corresponding Graph/Chart).....II-4

Table 4: Global VAD Market (2007): Implantations in Units by Select Player – Thoratec, MicroMed Cardiovascular, Berlin Heart, Ventracor, Terumo Heart and HeartWare (includes corresponding Graph/Chart).....II-4
1$300
   Competition Heats Up.....II-5
Competitive Technologies.....II-5
1$100
   Heart – The Vital Organ.....II-6
Heart Diseases.....II-6
Congenital Heart Disease.....II-6
Congestive Heart Failure.....II-6
Mechanical Circulatory Support Systems.....II-6
Total Artificial Heart.....II-6
1$100
   VADs.....II-7
VADs Usage by Indication and Time Duration.....II-7
1$100
   Types.....II-8
VAD Components.....II-8
VAD Pumps.....II-8
1$100
   Li-Ion Batteries: Reliable Power Sources for Portable Medical Devices.....II-9
Implantation Procedure.....II-9
Aftercare.....II-9
1$100
   Complications.....II-10
Infection.....II-10
Internal Bleeding.....II-10
Thrombus.....II-10
Table 5: Percentage Breakdown of Possible Complications in VADs Usage by Type – Infection, Bleeding, Arrhythmia, Renal Dysfunction, Respiratory Dysfunction, Neurologic Dysfunction, RV Dysfunction and Others (includes corresponding Graph/Chart).....II-10
1$300
   Pricing of VAD.....II-11
Table 6: Average Selling Prices of Select VADs by Company and Model.....II-11
VAD Improvisations.....II-11
1$300
   LVADs – An Introduction.....II-12
LVAD Milestones.....II-12
1$100
   An Effective Therapeutic Device for End-Stage Congestive Heart Failure.....II-13
Ventricular Assistance Vs. Heart Replacement.....II-13
2$200
   First Generation VAD.....II-15
Second Generation VAD.....II-15
Rotary Axial Flow Pumps.....II-15
1$100
   Drawbacks of Axial Flow Pump.....II-16
Third Generation VAD.....II-16
1$100
   Select First, Second and Third Generation Implantable VADs.....II-17
1$100
   Government Regulations.....II-18
The US.....II-18
Canada.....II-18
Europe.....II-18
1$100
   Thoratec Receives FDA Approval for its HeartMate II LVAS.....II-19
HeartWare Receives Conditional Approval for its HeartWare LVAS.....II-19
Abiomed Receives CE Mark for AB5000 Portable Driver.....II-19
Ventracor Receives USFDA Approval to Use its VentrAssist Device in Clinical
  Trials.....II-19
1$100
   NewCorTec Launches a New LVAD.....II-20
WorldHeart Launches New Pediatric VAD.....II-20
Ventracor Obtains FDA Approval for VentrAssist’s US BTT Trial.....II-20
MicroMed Cardiovascular Obtains 5-Year CE Mark Extension for DeBakey.....II-20
Thoratec Submits PMA for HeartMate II Left Ventricular Assist System.....II-20
Ventracor Receives ‘Commercial Ready’ Grant to Develop VentrAssist LVAD.....II-20
1$100
   Terumo Heart Obtains CE Mark for its DuraHeart® LVAS in Europe.....II-21
Abiomed Acquires Regulatory Approval in Australia for Impella LP 2.5 LVAD.....II-21
Abiomed Receives FDA Approval for Impella 2.5 VAD Pilot Trials.....II-21
Biophan Develops New MYO-VAD.....II-21
1$100
   Queensland University of Technology Invents Counter-Flow Pump.....II-22
HeartWare Obtains German Regulatory Approval for its HVAD™.....II-22
Abiomed Receives Regulatory Approval in France for its AB5000 VAD.....II-22
MiTi Develops MitiHeart LVAD for Heart Failure Patients.....II-22
1$100
   MicroMed Cardiovascular’s ‘DeBakey VAD Child’ Receives FDA Approval.....II-23
1$100
   UPMC Wins Gold Seal of Approval™ to Use VADs in Destination Therapy.....II-24
E-Wilson Acquires 97% of the MicroMed Cardiovascular’s Outstanding Shares.....II-24
World Heart Enters into Partnership with Abiomed.....II-24
1$100
   Thoratec Corporation Enters into Agreement with Levitronix.....II-25
World Heart Implants First Rotary VAD.....II-25
Abiomed Unveils a New Educational as well as Service Program.....II-25
1$100
   MicroMed Technology Merges with Salmon Express.....II-26
Abiomed Acquires Impella CardioSystems.....II-26
Thoratec Announces 40% Increase in Medicare Refund on VADs Used in DT.....II-26
National Heart, Lung and Blood Institute Awards Contract worth $6.95 Million.....II-26
2$200
   Abiomed, Inc. (USA).....II-28
Berlin Heart GmbH (Germany).....II-28
EvaHeart Medical USA, Inc. (USA).....II-28
HeartWare Limited (Australia).....II-28
Jarvik Heart, Inc. (USA).....II-28
1$100
   MEDOS Medizentechnik AG (Germany).....II-29
MicroMed Cardiovascular, Inc. (USA).....II-29
SynCardia Systems, Inc. (USA).....II-29
Terumo Heart, Inc. (USA).....II-29
Thoratec Corporation (USA).....II-29
1$100
   Ventracor Limited (Australia).....II-30
World Heart Corporation (USA).....II-30
1$100
   Table 7: World Recent Past, Current & Future Market Analysis for Ventricular Assist Devices by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....II-31

Table 8: World Historic Review for Ventricular Assist Devices by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....II-31
1$300
   Table 9: World 10-Year Perspective for Ventricular Assist Devices by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe, and Rest of World Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart).....II-321$300
   A. Market Analysis.....III-1
Heart Ailments – The Death Sentence.....III-1
Table 10: Incidence, Prevalence and Deaths due to Heart Ailments in the US (2007) (includes corresponding Graph/Chart).....III-1
Huge Waiting Time for Heart Transplant.....III-1
1$150
   VADs for Heart Failures.....III-2
Table 11: VAD Market in the US: Percentage Breakdown by Indication: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery and Others (includes corresponding Graph/Chart).....III-2
Market Dynamics.....III-2
High Selling Price.....III-2
Drug Industry Poses Intense Competition.....III-2
1$150
   Lack of Timely and Quick FDA Approvals.....III-3
Reimbursement.....III-3
CMS Increases LVAD Coverage for Heart Patients.....III-3
1$75
   New Facility Criteria to Hospitals on VAD Implantation for Destination
  Therapy.....III-4
Competition.....III-4
Table 12: Leading Players in the US Bridge-to-Transplant VAD Market (2008E) - Percentage Breakdown of Sales for Thoratec and Others.....III-4
1$150
   Table 13: Leading Players in the US destination therapy VAD Market (2007): Percentage Breakdown of Sales for Thoratec and Others.....III-5
Product Approvals/Innovations/Introductions.....III-5
2$300
   Strategic Corporate Developments.....III-73$225
   Key Players.....III-102$150
   B. Market Analytics.....III-12
Table 14: US Recent Past, Current & Future Analysis for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-12
1$150
   Table 15: US Historic Review for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-13
1$150
   A. Market Analysis.....III-14
Competitive landscape.....III-14
Next-generation VADs in Europe by Company (2007).....III-14
Table 16: Heart Transplants and Patients Waiting List in Europe (2005-2007): Figures in Units (includes corresponding Graph/Chart).....III-14
1$150
   Belgium.....III-15
Reimbursement Scenario.....III-15
Key Data.....III-15
Table 17: Belgium VAD Market (2002-2005): Implants in Units (includes corresponding Graph/Chart).....III-15

Table 18: Belgium VAD Market (2002-2005): BTT Implants in Units (includes corresponding Graph/Chart).....III-15
1$150
   Table 19: Belgium VAD Market (2004-2005): BTT Implants in Units by Device – Incor, Excor, Novacor, Thoratec, Medos, and TCI HM (includes corresponding Graph/Chart).....III-16
Germany.....III-16
The United Kingdom.....III-16
1$150
   Product Approvals/Innovations/Introductions.....III-171$75
   Strategic Corporate Development.....III-18
Key Players.....III-18
1$75
   B. Market Analytics.....III-19
Table 20: European Recent Past, Current & Future Analysis for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-19
1$150
   Table 21: European Historic Review for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-20
1$150
   A. Market Analysis.....III-21
Product Innovations/Approvals.....III-21
Strategic Corporate Development.....III-21
Key Players.....III-21
1$75
   B. Market Analytics.....III-22
Table 22: Rest of World Recent Past, Current & Future Analysis for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart).....III-22
1$150
   Table 23: Rest of World Historic Review for Ventricular Assist Devices Market Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2005 (includes corresponding Graph/Chart).....III-231$150